News
4h
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...
NOTE: This story discusses weight and eating disorders. If you or someone you know has an eating disorder, you can get help ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results